摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-溴-5-氯噻唑 | 16629-15-5

中文名称
2-溴-5-氯噻唑
中文别名
——
英文名称
2-bromo-5-chlorothiazole
英文别名
2-bromo-5-chloro-1,3-thiazole
2-溴-5-氯噻唑化学式
CAS
16629-15-5
化学式
C3HBrClNS
mdl
——
分子量
198.471
InChiKey
FYKOEXGDJNPHQV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    216.7±13.0 °C(Predicted)
  • 密度:
    1.979±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    7
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    41.1
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2934100090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335

SDS

SDS:65c83844b049a0e383acc5cb1ec26049
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Bromo-5-chlorothiazole
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Bromo-5-chlorothiazole
CAS number: 16629-15-5

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C3HBrClNS
Molecular weight: 198.5

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, hydrogen bromide, sulfur
oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    2-溴-5-氯噻唑二氯(N,N,N',N'-四甲基乙二胺)锌(II)lithium diisopropyl amide 作用下, 以 四氢呋喃 为溶剂, 以81 %的产率得到2,4-dibromo-5-chlorothiazole
    参考文献:
    名称:
    通过逐步反应进行溴芳烃的正式卤素转移
    摘要:
    报道了溴代芳烃的两步卤素转移。通过去质子锂化产生的单溴芳基锂、二溴芳基锂和三溴芳基锂通过原位锌化转化为有机锌物质,然后进行溴化,分别提供相应的二溴芳烃、三溴芳烃和四溴芳烃,产率 41-95%。与乙基氯化镁进行区域选择性溴-镁交换,然后进行亲电捕获,得到苯、吡啶、喹啉、嘧啶和噻唑衍生物,其中溴基团从原始位置转移,产率为 28-86%。
    DOI:
    10.1021/acs.orglett.3c02540
  • 作为产物:
    描述:
    5-氯-2-氨基噻唑亚硝酸特丁酯copper(ll) bromide 作用下, 以 乙腈 为溶剂, 反应 18.5h, 生成 2-溴-5-氯噻唑
    参考文献:
    名称:
    [EN] PYRROLONE MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS
    [FR] ANTAGONISTES DE RÉCEPTEUR D'HORMONE CONCENTRANT LA MÉLANINE 1 DE TYPE PYRROLONE
    摘要:
    本申请提供了根据公式I提供的化合物,包括所有立体异构体、溶剂合物、前药和药用可接受形式,其中R1、公式Ia、R4、R5、公式Ib、R3、R3a、W、D、R2a、R2b和R2c在此处定义。此外,本申请提供了含有至少一种根据公式I的化合物和可选至少一种额外治疗剂的药物组合物。最后,本申请提供了治疗患有MCHR-1调节性疾病或紊乱的患者的方法,例如肥胖、糖尿病、抑郁症、焦虑或肠道炎症,通过给予根据公式I的化合物的治疗有效剂量。
    公开号:
    WO2010042674A1
点击查看最新优质反应信息

文献信息

  • [EN] TYK2 INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE TYK2 ET LEURS UTILISATIONS
    申请人:NIMBUS LAKSHMI INC
    公开号:WO2018071794A1
    公开(公告)日:2018-04-19
    The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
    本发明提供了化合物、其组合物以及使用它们来抑制TYK2并治疗TYK2介导的疾病的方法。
  • Substituted 1-propiolylpiperazine compounds, their preparation and use
    申请人:Kuhnert Sven
    公开号:US20070112011A1
    公开(公告)日:2007-05-17
    Substituted 1-propiolylpiperazine compounds corresponding to formula I in which X denotes N or C—R 2 , and n is an integer from 0 to 8, a method for producing such substituted 1-propiolylpiperazine compounds, pharmaceutical compositions containing such substituted 1-propiolylpiperazine compounds, and the use of such substituted 1-propiolylpiperazine compounds for modulating mGluR5 receptor activity or for treating or inhibiting pain and various other conditions, especially conditions at least partly mediated by the mGluR5 receptor.
    将符合公式I的1-丙炔基哌嗪化合物替代为X代表N或C—R,n为0至8的整数,一种生产这种替代的1-丙炔基哌嗪化合物的方法,含有这种替代的1-丙炔基哌嗪化合物的药物组合物,以及利用这种替代的1-丙炔基哌嗪化合物调节mGluR5受体活性或用于治疗或抑制疼痛和其他各种病症,特别是至少部分由mGluR5受体介导的病症。
  • [EN] 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES<br/>[FR] BENZAMIDES À SUBSTITUTION 1,3-THIAZOL-2-YL
    申请人:EVOTEC AG
    公开号:WO2016091776A1
    公开(公告)日:2016-06-16
    The present invention relates to 1,3-thiazol-2-yl substituted benzamide compounds of general formula (I) as described and defined herein, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neurogenic disorder, as a sole agent or in combination with other active ingredients.
    本发明涉及一般式(I)所述和定义的1,3-噻唑-2-基取代苯甲酰胺化合物,以及包含所述化合物的药物组合物和药物组合物的用途,用于制造用于治疗或预防疾病的药物组合物,特别是神经源性疾病,作为唯一药剂或与其他活性成分组合使用。
  • TGF BETA R ANTAGONISTS
    申请人:Bristol-Myers Squibb Company
    公开号:US20160176871A1
    公开(公告)日:2016-06-23
    The invention relates generally to compounds that modulate the activity of TGFβR-1 and TGFβR-2, pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.
    这项发明通常涉及调节TGFβR-1和TGFβR-2活性的化合物,包含这些化合物的药物组合物以及利用该发明的化合物治疗增殖性疾病和失调凋亡疾病(如癌症)的方法。
  • [EN] HERBICIDAL THIAZOLE COMPOUNDS<br/>[FR] COMPOSÉS DE THIAZOLE HERBICIDES
    申请人:SYNGENTA CROP PROTECTION AG
    公开号:WO2021094504A1
    公开(公告)日:2021-05-20
    The present invention relates to compounds of Formula (I), or an agronomically acceptable salt of said compounds wherein Q, R1, R3, R4 and n are as defined herein. The invention further relates to herbicidal compositions which comprise a compound of Formula (I) and to the use of compounds of Formula (I) for controlling weeds, in particular in crops of useful plants.
    本发明涉及式(I)的化合物,或者所述化合物的农业上可接受的盐,其中Q、R1、R3、R4和n如本文所定义。本发明还涉及包括式(I)化合物的除草剂组合物,以及利用式(I)化合物来控制杂草,特别是在有用植物作物中的使用。
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺